Differential antigen-processing pathways of the hepatitis B virus e and core proteins

Area of Science:

• Immunology
• Virology
• Hepatitis B Research

Background:

• Hepatitis B e antigen (HBeAg) and hepatitis B core antigen (HBcAg) have distinct roles in antiviral immunity.
• Both antigens share CD4(+) T-cell epitopes, processable via exogenous pathways.

Purpose of the Study:

• To investigate antigen-presenting cells' capacity to present epitopes from endogenously synthesized HBcAg/HBeAg on HLA class II molecules.
• To understand the differential presentation of HBeAg and HBcAg in the context of Hepatitis B infection.

Main Methods:

• Utilized lymphoblastoid cell lines infected with recombinant vaccinia viruses encoding HBcAg or HBeAg constructs.
• Assessed the ability of these cells and stable transfectants to stimulate HBcAg/HBeAg-specific CD4(+) T-cell clones.
• Investigated antigen processing pathways using brefeldin A and chloroquin.

Main Results:

• Antigen-presenting cells expressing HBeAg constructs stimulated CD4(+) T-cell clones, unlike those with HBcAg constructs.
• HBeAg-induced T-cell activation was sensitive to brefeldin A (endogenous pathway) but resistant to chloroquin (exogenous pathway).
• Exogenous HBcAg-induced T-cell activation was sensitive to chloroquin but resistant to brefeldin A.

Conclusions:

• Endogenously synthesized HBeAg can be processed and presented on HLA class II molecules by infected cells, including hepatocytes.
• This presentation mechanism may play a role in regulating CD4(+) T-cell responses during Hepatitis B infection.
• Highlights distinct antigen-processing and presentation pathways for HBeAg and HBcAg.